ARCHIVES

Pretreatment with Azacitidine Achieves 28-Month Remission

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

In Brief: Berlin Leaving Northwestern To Become Zubrod’s Deputy at Miami; Four Center Director Jobs Open

August 7, 1987

Drug Shortages: Institutions Report Halting Enrollment in Clinical Trials

March 22, 2013

A Conversation With Daniel Masys: Acronym “CABIG” Could Be Eliminated

January 6, 2012

NIH reauthorization Bill slates For House Vote;

May 28, 1993

NCI Programs: Institute Partners With Two Groups On Psychosocial Issues

May 16, 1997